ST. LOUIS, MISSOURI DRUG INJURY LAWYERS

Belviq was first approved by the Food and Drug Administration in 2012 and sold to consumers in 2013 as a way to help users manage their weight. Clinical trials have now shown a link between Belviq, also known as lorcaserin, and certain types of cancer. Find out why people are now filing lawsuits to get compensation from the drug’s manufacturer.

Beovu is supposed to treat wet age-related macular degeneration. However, the American Society of Retina Specialists has discovered that Beovu may instead cause blindness in some patients.

The Type 2 diabetes drugs Byetta^®, Januvia^®, and Janumet^® have been linked to an increased risk of serious health problems affecting the pancreas, including pancreatic cancer.

Elmiron is prescribed to treat bladder pain resulting from cystitis. There’s growing evidence that this medication is linked to maculopathy, an eye disorder that could lead to vision loss. People are now taking legal action against the drug’s manufacturer to get the compensation they’re entitled to.

Proton pump inhibitors (PPIs), a class of prescription heartburn drugs, are used to reduce acid in a patient’s stomach. But many of the most popular PPIs have been linked to serious health risks, including chronic kidney disease.

PrEP drugs, including Truvada^®, Atripla^®, Viread^®, Stribild^®, and Complera^®, help prevent HIV in patients at high risk of HIV and other STDs. However, people who take these medications may be at risk of serious and harmful side effects including kidney disease and bone density loss. When drug companies don’t warn users of the health risks their products can cause, they should be held responsible.

Iron-deficiency anemia is the most common type of anemia, but many patients with this condition are unable to take or tolerate iron supplements. These patients, along with certain patients with chronic kidney disease who aren’t receiving dialysis, can be treated with an injectable iron complex called Injectafer.

Patients taking the Type 2 diabetes drugs, Invokana and Invokamet, may face an increased risk of ketoacidosis—a condition where the body produces high levels of acid in the blood.

A variety of patches, injections, and gels are marketed to men as ways to increase testosterone levels. But testosterone therapy drugs have been linked to an increased risk of heart attack, stroke, and even death in some male patients.

An FDA advisory committee concluded taking the prescription Type 2 diabetes drug Onglyza® (saxagliptin) can increase the risk of heart failure—a fatal condition.

In Canada and Europe, Teva Pharmaceuticals warned healthcare providers that Provigil could cause birth defects, prompting doctors to stop prescribing the medication to pregnant women.

Taxotere^®, an injectable concentrate used during chemotherapy treatment for cancer, has been linked to permanent hair loss in female breast cancer survivors.

Tepezza (teprotumumab) was approved by the U.S. Food and Drug Administration (FDA) in January 2020 as one of the first medications to successfully treat the symptoms of thyroid eye disease (TED).

For years, expecting mothers have relied on Tylenol (acetaminophen) to relieve pain. Studies now suggest that there’s a strong link between a fetus’s exposure to acetaminophen and an increased likelihood of autism.

Valsartan is widely used to treat high blood pressure. Certain batches of this medication have been contaminated by N-nitrosodimethylamine (NDMA), a cancer-causing agent. For people that have diagnosed with cancer after taking Valsartan, now’s the time to take legal action.

The erectile dysfunction drug Viagra^® has been linked to an increased risk of melanoma—an aggressive form of skin cancer—in male patients, regardless of family history, medical history, or ultraviolet light exposure.

Mainstream and social media coverage have created a surge in the usage of injectable type 2 diabetes medications, such as Ozempic and Rybelsus, for weight loss purposes. While these glucagon-like peptide-1 (GLP-1) agonists were originally formulated to assist type 2 diabetes patients in regulating their blood sugar levels, they have recently emerged as effective tools for weight reduction. This unforeseen benefit has led medical practitioners to prescribe them off-label for weight loss, alongside another GLP-1 agonist named Wegovy, which is designed and prescribed exclusively for weight loss.

Did you or a loved one develop blood clots in your lungs after taking Xeljanz^®? If so, you may be eligible for compensation, and we want to help you get it.

Heartburn drug Zantac and generic ranitidine contain dangerous levels of NDMA, a probable carcinogen. It’s our goal to help people who developed cancer after taking this medication.

Zofran^® is sometimes prescribed to pregnant women to treat symptoms of severe morning sickness. But new data suggests that babies born to women who take the drug may face an increased risk of certain birth defects.